Lv3
318 积分 2023-09-18 加入
Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype
21天前
已完结
Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial
1个月前
已完结
Type 2 inflammation biomarkers and their association with response to dupilumab in COPD (BOREAS): an analysis of a randomised, placebo-controlled, phase 3 trial
2个月前
已完结
Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial
3个月前
已完结
Mepolizumab Prevents COPD Exacerbations in Trial
3个月前
已完结
Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype
3个月前
已完结
Spatial adaptation of eosinophils and their emerging roles in homeostasis, infection and disease
3个月前
已完结
Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial
3个月前
已完结
Bullous pemphigoid: Its incidence, mortality and clinical outcome in New Zealand
3个月前
已完结
Ethnic variations in the epidemiology of bullous pemphigoid in Israel
3个月前
已完结
皖公网安备34019202002308
